Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Chronic Lymphocytic Leukemia (CLL)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00003116
What this trial is testing

High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+2 more
Case Comprehensive Cancer Center 66
Not applicableLooking for participantsNCT01087333
What this trial is testing

Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment

Who this might be right for
Hairy Cell Leukemia (HCL)Chronic Lymphocytic Leukemia (CLL)Non-Hodgkins Lymphoma (NHL)+2 more
National Cancer Institute (NCI) 1,263
Testing effectiveness (Phase 2)Study completedNCT00118352
What this trial is testing

Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Acute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+61 more
Fred Hutchinson Cancer Center 12
Early research (Phase 1)WithdrawnNCT00024115
What this trial is testing

BL22 Immunotoxin in Treating Patients With Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphoma
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00644189
What this trial is testing

Oral Clofarabine for Relapsed/Refractory Non-Hodgkin Lymphoma

Who this might be right for
Follicular LymphomaMarginal Zone LymphomaMantle Cell Lymphoma+7 more
Massachusetts General Hospital 50
Testing effectiveness (Phase 2)Looking for participantsNCT06544785
What this trial is testing

Zanubrutinib With Obinutuzumab in Untreated Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
PETHEMA Foundation 106
Early research (Phase 1)Study completedNCT01682616
What this trial is testing

A Phase 1b Study Evaluating the Safety and Tolerability of ABT-199 in Combination With Rituximab in Subjects With Relapsed Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

Who this might be right for
Small Lymphocytic LymphomaChronic Lymphocytic Leukemia
AbbVie 49
Not applicableStudy completedNCT02553447
What this trial is testing

Cholecalciferol in Newly Diagnosed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia With Vitamin D Deficiency

Who this might be right for
Chronic Lymphocytic LeukemiaNon-Hodgkin LymphomaUntreated Chronic Lymphocytic Leukemia+1 more
University of Nebraska 197
Early research (Phase 1)Ended earlyNCT00004058
What this trial is testing

12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
University of Medicine and Dentistry of New Jersey
Testing effectiveness (Phase 2)Study completedNCT01789255
What this trial is testing

Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+115 more
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Ended earlyNCT00751296
What this trial is testing

Study of Lenalidomide in Previously Untreated, Symptomatic Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukaemia
University Health Network, Toronto 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT04447768
What this trial is testing

The Combination of Venetoclax and Obinutuzumab in People With Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)
Memorial Sloan Kettering Cancer Center 100
Early research (Phase 1)UnknownNCT00022880
What this trial is testing

Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Corixa Corporation 30
Testing effectiveness (Phase 2)Ended earlyNCT00183950
What this trial is testing

Study of Noscapine for Patients With Low Grade Non Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia Refractory to Chemotherapy

Who this might be right for
Non-Hodgkin's LymphomaChronic Lymphocytic Leukemia
University of Southern California 12
Testing effectiveness (Phase 2)Study completedNCT01010217
What this trial is testing

Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide

Who this might be right for
Blood Stem Cell Transplant FailureLeukemiaHematologic Malignancies
M.D. Anderson Cancer Center 176
Early research (Phase 1)Study completedNCT00714103
What this trial is testing

8-Chloro-Adenosine in Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaChronic Lymphocytic Leukemia
M.D. Anderson Cancer Center 11
Early research (Phase 1)Ended earlyNCT05244070
What this trial is testing

Evaluate the Safety and Tolerability of BMS-986403 in Participants With Relapsed and/or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-CellLymphoma
Bristol-Myers Squibb 5
Early research (Phase 1)Ended earlyNCT01076556
What this trial is testing

Cyclophosphamide, Alvocidib, and Rituximab in Treating Patients With High Risk B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
Chronic Lymphocytic LeukemiaProlymphocytic LeukemiaRecurrent Small Lymphocytic Lymphoma+9 more
National Cancer Institute (NCI) 9
Testing effectiveness (Phase 2)Study completedNCT00003829
What this trial is testing

Chemotherapy in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia
Alliance for Clinical Trials in Oncology 34
Early research (Phase 1)Study completedNCT00036946
What this trial is testing

VEGF Trap in Treating Patients With Relapsed or Refractory Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
Regeneron Pharmaceuticals
Next Page